Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Haddon Smith"'
Autor:
Jimiece Thomas, Haddon Smith, C. Aaron Smith, Lori Coward, Gregory Gorman, Maria De Luca, Patricia Jumbo-Lucioni
Publikováno v:
Pathophysiology, Vol 28, Iss 2, Pp 307-319 (2021)
The use of angiotensin-converting enzyme inhibitors (ACEis) has been reported to reduce symptoms of cognitive decline in patients with Alzheimer’s disease (AD). Yet, the protective role of ACEis against AD symptoms is still controversial. Here, we
Externí odkaz:
https://doaj.org/article/484a9af10daa4d979d916ab5182e9d36
Autor:
C. Aaron Smith, Haddon Smith, Lisa Roberts, Lori Coward, Gregory Gorman, Amrisha Verma, Qiuhong Li, Thomas W. Buford, Christy S. Carter, Patricia Jumbo-Lucioni
Publikováno v:
J Alzheimers Dis
Background: While extensive research on the brain has failed to identify effective therapies, using probiotics to target the gut microbiome has shown therapeutic potential in Alzheimer’s disease (AD). Genetically modified probiotics (GMP) are a pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c21d17a4baa5a5a05735b312e6d92488
https://doi.org/10.3233/jad-210464
https://doi.org/10.3233/jad-210464
Autor:
C. Aaron Smith, Patricia Jumbo-Lucioni, Haddon Smith, Jimiece Thomas, Lori Coward, Maria De Luca, Gregory Gorman
Publikováno v:
Pathophysiology, Vol 28, Iss 20, Pp 307-319 (2021)
Pathophysiology
Volume 28
Issue 2
Pages 20-319
Pathophysiology
Volume 28
Issue 2
Pages 20-319
The use of angiotensin-converting enzyme inhibitors (ACEis) has been reported to reduce symptoms of cognitive decline in patients with Alzheimer’s disease (AD). Yet, the protective role of ACEis against AD symptoms is still controversial.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d0c0694988e73f3832075e78588ba2c
https://www.mdpi.com/1873-149X/28/2/20
https://www.mdpi.com/1873-149X/28/2/20